Macroeconomic and pharma-specific indicators backed up Lilly's investment decision

Case study about how macroeconomic and pharma-specific indicators backed up Lilly's investment decision in Alzey, Germany

The case study explores the strategic rationale of the U.S. pharma company Eli Lilly choosing Alzey, Germany as a new production site by analysing macroeconomic and industry-specific ratios.

Download

Download now!

We will send the link to the file to this address.

This website uses cookies to ensure you get the best experience on our website. By continuing to use the website, you agree to the use of cookies. For more information about cookies, please visit ourprivacy policy.